2024

There have been no clinical safety alerts issued in 2024 to date.

2023

• Cases of harm linked to strong opioids (nitazenes) in refillable vape (e-cigarette) liquids [Issued 7 November 2023]​​
• Composition of counterfeit alprazolam in NSW [Issued 3 November 2023]
• Illicit cocaine containing high levels of lidocaine (lignocaine) [Issued 4 May 2023]

2022

• Strong opioids detected in counterfeit 'Kalma' tablets [Issued 26 Augu​st 2022]
• Unregistered benzodiazepines and counterfeit alprazolam prod​ucts [Issued 1 August 2022, superseded 3 November 2023]

2021

• Illicit cocaine containing high levels of lidocaine (lignocaine) [Issued 13 August 2021, superseded 4 May 2023]
• 25C-NBOMe toxicity in patients who used powder thought to be MDMA [Issued 2 July 2021]
• Illicit cocaine containing strong opioids [Issued 14 May 2021]

2020

• Heroin and cocaine containing fentanyl and acetylfentanyl [Issued 26 November 2020]
• Acetylfentanyl and fentanyl in non-opioid illicit drugs [Issued 16 October 2020]
• Illicit supply of counterfeit alprazolam [Issued 16 July 2020, updated 9 September 2020, superseded 1 August 2022]
• Acetylfentanyl Clinical Alert [Issued 21 February 2020]

2019

Carfentanil Safety Alert [Issued 12 December 2019]​